INFLIXIMAB INFLIXIMAB (11489Q) infliximab 100 mg injection, 1 vial 11489Q Body System: Antineoplastic And Immunomodulating Agents > Immunosuppressants > Immunosuppressants Manner of administration:Injection Private S100 HSD Private Authority Required Restriction Indication: Ankylosing spondylitis Treatment phase: Subsequent continuing treatment Quantities & Cost Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $202.85 Max safety net: $25.00 General Patient Charge: $25.00 Available brands Inflectra Ixifi Remicade Remsima Renflexis
